JP Morgan Chase’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.2B | Sell |
71,713,442
-20,761,752
| -22% | -$1.19B | 0.23% | 89 |
|
|
2026
Q1 | $5.52B | Buy |
92,475,194
+17,107,541
| +23% | +$997M | 0.35% | 51 |
|
|
2025
Q4 | $4.07B | Sell |
75,367,653
-10,813,011
| -13% | -$520M | 0.26% | 86 |
|
|
2025
Q3 | $3.89B | Sell |
86,180,664
-17,780,210
| -17% | -$830M | 0.23% | 93 |
|
|
2025
Q2 | $4.81B | Sell |
103,960,874
-4,091,630
| -4% | -$201M | 0.31% | 64 |
|
|
2025
Q1 | $6.59B | Buy |
108,052,504
+12,029,292
| +13% | +$701M | 0.48% | 31 |
|
|
2024
Q4 | $5.43B | Buy |
96,023,212
+18,093,184
| +23% | +$1.01B | 0.4% | 36 |
|
|
2024
Q3 | $4.03B | Buy |
77,930,028
+3,300,102
| +4% | +$155M | 0.31% | 64 |
|
|
2024
Q2 | $3.1B | Sell |
74,629,926
-14,184,197
| -16% | -$635M | 0.25% | 83 |
|
|
2024
Q1 | $4.82B | Sell |
88,814,123
-1,234,151
| -1% | -$62.9M | 0.41% | 47 |
|
|
2023
Q4 | $4.62B | Sell |
90,048,274
-6,692,109
| -7% | -$351M | 0.44% | 44 |
|
|
2023
Q3 | $5.61B | Sell |
96,740,383
-6,573,182
| -6% | -$403M | 0.62% | 22 |
|
|
2023
Q2 | $6.61B | Buy |
103,313,565
+6,699,923
| +7% | +$449M | 0.72% | 16 |
|
|
2023
Q1 | $6.7B | Sell |
96,613,642
-2,049,834
| -2% | -$145M | 0.82% | 15 |
|
|
2022
Q4 | $7.1B | Sell |
98,663,476
-834,677
| -0.8% | -$62.9M | 0.94% | 8 |
|
|
2022
Q3 | $7.07B | Buy |
99,498,153
+1,737,893
| +2% | +$126M | 1.02% | 9 |
|
|
2022
Q2 | $7.53B | Buy |
97,760,260
+3,876,301
| +4% | +$295M | 1.05% | 9 |
|
|
2022
Q1 | $6.86B | Buy |
93,883,959
+2,133,783
| +2% | +$143M | 0.83% | 13 |
|
|
2021
Q4 | $5.72B | Buy |
91,750,176
+6,172,949
| +7% | +$362M | 0.66% | 18 |
|
|
2021
Q3 | $5.06B | Buy |
85,577,227
+2,279,075
| +3% | +$150M | 0.63% | 18 |
|
|
2021
Q2 | $5.57B | Buy |
83,298,152
+7,255,243
| +10% | +$473M | 0.66% | 18 |
|
|
2021
Q1 | $4.8B | Buy |
76,042,909
+3,693,696
| +5% | +$230M | 0.64% | 16 |
|
|
2020
Q4 | $4.49B | Buy |
72,349,213
+5,988,179
| +9% | +$368M | 0.66% | 18 |
|
|
2020
Q3 | $3.98B | Buy |
66,361,034
+1,807,968
| +3% | +$109M | 0.67% | 21 |
|
|
2020
Q2 | $3.8B | Buy |
64,553,066
+4,119,542
| +7% | +$246M | 0.73% | 16 |
|
|
2020
Q1 | $3.37B | Buy |
60,433,524
+8,947,046
| +17% | +$547M | 0.79% | 13 |
|
|
2019
Q4 | $3.3B | Buy |
51,486,478
+15,871,346
| +45% | +$909M | 0.62% | 24 |
|
|
2019
Q3 | $1.81B | Buy |
35,615,132
+10,715,158
| +43% | +$504M | 0.36% | 52 |
|
|
2019
Q2 | $1.12B | Buy |
24,899,974
+7,838,275
| +46% | +$365M | 0.22% | 94 |
|
|
2019
Q1 | $814M | Sell |
17,061,699
-1,612,592
| -9% | -$80.3M | 0.17% | 133 |
|
|
2018
Q4 | $971M | Sell |
18,674,291
-1,015,526
| -5% | -$54.6M | 0.22% | 100 |
|
|
2018
Q3 | $1.22B | Sell |
19,689,817
-3,115,958
| -14% | -$185M | 0.23% | 91 |
|
|
2018
Q2 | $1.26B | Buy |
22,805,775
+255,589
| +1% | +$13.8M | 0.26% | 79 |
|
|
2018
Q1 | $1.43B | Sell |
22,550,186
-1,964,112
| -8% | -$126M | 0.31% | 57 |
|
|
2017
Q4 | $1.5B | Buy |
24,514,298
+1,980,157
| +9% | +$124M | 0.32% | 57 |
|
|
2017
Q3 | $1.42B | Sell |
22,534,141
-10,214
| -0% | -$596K | 0.31% | 58 |
|
|
2017
Q2 | $1.26B | Sell |
22,544,355
-2,197,486
| -9% | -$120M | 0.29% | 70 |
|
|
2017
Q1 | $1.35B | Sell |
24,741,841
-4,148,974
| -14% | -$228M | 0.31% | 61 |
|
|
2016
Q4 | $1.69B | Sell |
28,890,815
-3,992,914
| -12% | -$218M | 0.41% | 36 |
|
|
2016
Q3 | $1.77B | Sell |
32,883,729
-5,925,985
| -15% | -$381M | 0.44% | 36 |
|
|
2016
Q2 | $2.85B | Buy |
38,809,714
+5,617,459
| +17% | +$397M | 0.71% | 16 |
|
|
2016
Q1 | $2.12B | Buy |
33,192,255
+711,880
| +2% | +$44.9M | 0.54% | 27 |
|
|
2015
Q4 | $2.23B | Sell |
32,480,375
-1,097,721
| -3% | -$72.5M | 0.56% | 25 |
|
|
2015
Q3 | $1.99B | Sell |
33,578,096
-4,175,206
| -11% | -$265M | 0.53% | 30 |
|
|
2015
Q2 | $2.51B | Buy |
37,753,302
+1,968,331
| +6% | +$130M | 0.59% | 24 |
|
|
2015
Q1 | $2.31B | Buy |
35,784,971
+2,088,522
| +6% | +$131M | 0.53% | 29 |
|
|
2014
Q4 | $1.99B | Sell |
33,696,449
-3,697,347
| -10% | -$209M | 0.45% | 33 |
|
|
2014
Q3 | $1.91B | Sell |
37,393,796
-5,971,744
| -14% | -$298M | 0.45% | 36 |
|
|
2014
Q2 | $2.1B | Sell |
43,365,540
-781,513
| -2% | -$38.5M | 0.53% | 27 |
|
|
2014
Q1 | $2.29B | Buy |
44,147,053
+2,455,629
| +6% | +$131M | 0.63% | 22 |
|
|
2013
Q4 | $2.22B | Sell |
41,691,424
-2,287,203
| -5% | -$117M | 0.63% | 22 |
|
|
2013
Q3 | $2.04B | Buy |
43,978,627
+9,291,026
| +27% | +$408M | 0.6% | 22 |
|
|
2013
Q2 | $1.55B | Buy |
+34,687,601
| New | +$1.51B | 0.49% | 31 |
|
Other funds holding BMY
VCM
VPM
JP Morgan Chase's BMY Position: Q2 2026 in Review
JP Morgan Chase reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, selling an estimated $1.19B and leaving 71,713,442 shares worth $4.2B. The position accounts for 0.23% of the portfolio, ranked #89.
JP Morgan Chase first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.53B in Q2 2022. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- JP Morgan Chase held 71,713,442 shares of Bristol-Myers Squibb worth $4.2B as of Q2 2026.
- JP Morgan Chase sold 20,761,752 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.19B.
- Bristol-Myers Squibb made up 0.23% of JP Morgan Chase's portfolio in Q2 2026, its #89 holding.
- JP Morgan Chase first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Bristol-Myers Squibb position peaked at $7.53B in Q2 2022.
- 2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.